End-to-End Continuous Small-Scale Drug Substance Manufacturing: From a Continuous In Situ Nucleator to Free-Flowing Crystalline Particles

In the evolving landscape of pharmaceutical manufacturing, a comprehensive continuous production process is being crafted for the small-scale production of active pharmaceutical ingredients. This study focuses on continuous crystallization with separate nucleation and crystal growth units, as well a...

Full description

Bibliographic Details
Main Authors: Anne Cathrine Kufner, Marc Meier, Kerstin Wohlgemuth
Format: Article
Language:English
Published: MDPI AG 2023-12-01
Series:Crystals
Subjects:
Online Access:https://www.mdpi.com/2073-4352/13/12/1675
_version_ 1797381475504488448
author Anne Cathrine Kufner
Marc Meier
Kerstin Wohlgemuth
author_facet Anne Cathrine Kufner
Marc Meier
Kerstin Wohlgemuth
author_sort Anne Cathrine Kufner
collection DOAJ
description In the evolving landscape of pharmaceutical manufacturing, a comprehensive continuous production process is being crafted for the small-scale production of active pharmaceutical ingredients. This study focuses on continuous crystallization with separate nucleation and crystal growth units, as well as continuous downstream processing, encompassing filtration, washing, and drying until the formation of free-flowing particles. We introduce a novel continuous nucleator designed based on solubility data and produced via 3D printing, enabling the fast and precise small-scale manufacturing of a nucleator meeting the requirements for nucleation and further growth processes. The nucleator is evaluated with regard to its suitability for continuous long-term operation across various coupled crystallizers. As a practical application example, it is connected to a slug flow crystallizer to enable high-quality continuous crystallization. Additionally, the full integration of downstream processes using a continuous vacuum screw filter to achieve free-flowing product particles is realized. Even under non-optimized process conditions, with the help of the in situ generation of nuclei, free-flowing product particles are successfully obtained. This is particularly useful during drug development when no material is available for seed addition and to quickly obtain products for further characterization.
first_indexed 2024-03-08T20:53:02Z
format Article
id doaj.art-b8f6ceb50b4e429290a287f1b944df72
institution Directory Open Access Journal
issn 2073-4352
language English
last_indexed 2024-03-08T20:53:02Z
publishDate 2023-12-01
publisher MDPI AG
record_format Article
series Crystals
spelling doaj.art-b8f6ceb50b4e429290a287f1b944df722023-12-22T14:01:58ZengMDPI AGCrystals2073-43522023-12-011312167510.3390/cryst13121675End-to-End Continuous Small-Scale Drug Substance Manufacturing: From a Continuous In Situ Nucleator to Free-Flowing Crystalline ParticlesAnne Cathrine Kufner0Marc Meier1Kerstin Wohlgemuth2Laboratory of Plant and Process Design, Department of Biochemical and Chemical Engineering, TU Dortmund University, D-44227 Dortmund, GermanyLaboratory of Plant and Process Design, Department of Biochemical and Chemical Engineering, TU Dortmund University, D-44227 Dortmund, GermanyLaboratory of Plant and Process Design, Department of Biochemical and Chemical Engineering, TU Dortmund University, D-44227 Dortmund, GermanyIn the evolving landscape of pharmaceutical manufacturing, a comprehensive continuous production process is being crafted for the small-scale production of active pharmaceutical ingredients. This study focuses on continuous crystallization with separate nucleation and crystal growth units, as well as continuous downstream processing, encompassing filtration, washing, and drying until the formation of free-flowing particles. We introduce a novel continuous nucleator designed based on solubility data and produced via 3D printing, enabling the fast and precise small-scale manufacturing of a nucleator meeting the requirements for nucleation and further growth processes. The nucleator is evaluated with regard to its suitability for continuous long-term operation across various coupled crystallizers. As a practical application example, it is connected to a slug flow crystallizer to enable high-quality continuous crystallization. Additionally, the full integration of downstream processes using a continuous vacuum screw filter to achieve free-flowing product particles is realized. Even under non-optimized process conditions, with the help of the in situ generation of nuclei, free-flowing product particles are successfully obtained. This is particularly useful during drug development when no material is available for seed addition and to quickly obtain products for further characterization.https://www.mdpi.com/2073-4352/13/12/1675continuous manufacturingcontinuous nucleation3D printingcontinuous downstreamsmall-scale productionhigh-quality products
spellingShingle Anne Cathrine Kufner
Marc Meier
Kerstin Wohlgemuth
End-to-End Continuous Small-Scale Drug Substance Manufacturing: From a Continuous In Situ Nucleator to Free-Flowing Crystalline Particles
Crystals
continuous manufacturing
continuous nucleation
3D printing
continuous downstream
small-scale production
high-quality products
title End-to-End Continuous Small-Scale Drug Substance Manufacturing: From a Continuous In Situ Nucleator to Free-Flowing Crystalline Particles
title_full End-to-End Continuous Small-Scale Drug Substance Manufacturing: From a Continuous In Situ Nucleator to Free-Flowing Crystalline Particles
title_fullStr End-to-End Continuous Small-Scale Drug Substance Manufacturing: From a Continuous In Situ Nucleator to Free-Flowing Crystalline Particles
title_full_unstemmed End-to-End Continuous Small-Scale Drug Substance Manufacturing: From a Continuous In Situ Nucleator to Free-Flowing Crystalline Particles
title_short End-to-End Continuous Small-Scale Drug Substance Manufacturing: From a Continuous In Situ Nucleator to Free-Flowing Crystalline Particles
title_sort end to end continuous small scale drug substance manufacturing from a continuous in situ nucleator to free flowing crystalline particles
topic continuous manufacturing
continuous nucleation
3D printing
continuous downstream
small-scale production
high-quality products
url https://www.mdpi.com/2073-4352/13/12/1675
work_keys_str_mv AT annecathrinekufner endtoendcontinuoussmallscaledrugsubstancemanufacturingfromacontinuousinsitunucleatortofreeflowingcrystallineparticles
AT marcmeier endtoendcontinuoussmallscaledrugsubstancemanufacturingfromacontinuousinsitunucleatortofreeflowingcrystallineparticles
AT kerstinwohlgemuth endtoendcontinuoussmallscaledrugsubstancemanufacturingfromacontinuousinsitunucleatortofreeflowingcrystallineparticles